Puretech Health plc (PRTC) Ordinary 1p

- Add to watchlist
- Create an alert
- This stock can be held in a




Share news, reports & tips
-
PureTech reports 'Glyph' milestone, disappointing long Covid results
14 June 2022 07:33
(Sharecast News) - PureTech Health said on Tuesday that it had met a milestone in proving its 'Glyph' therapeutic platform, while separately announcing disappointing results from a study into long...
-
PureTech to buy back up to $50m of shares
5 May 2022 10:09
(Sharecast News) - PureTech Health has announced a $50m share buyback programme, sending shares in the FTSE 250 biotech sharply higher.
-
Puretech Health receives $100m from sale of 55% stake in Karuna Therapeutics
10 November 2021 09:15
(Sharecast News) - Biotechnology company Puretech Health has received approximately $100.0m in cash from the sale of a portion of the group's shares in its founded entity Karuna Therapeutics.
-
PureTech Health's Vor wins FDA fast-track approval for cancer drug
10 September 2021 07:38
(Sharecast News) - Clinical stage biotherapeutics firm PureTech Health on Friday said its founded entity, Vor Biopharma, had won US fast track approval for its leukaemia treatment.
-
Tuesday broker round-up
24 August 2021 14:34
(Sharecast News) - Coats: Jefferies starts at buy with 97.0p target price.
-
PureTech in 'strong' position despite swinging to net loss
24 August 2021 07:42
(Sharecast News) - Biotechnology company PureTech Health swung to a loss in its first half, it said on Tuesday, amid rising costs.
-
Director dealings: Puretech Health director raises stake
22 July 2021 15:35
(Sharecast News) - Puretech Health revealed on Thursday that director Bharatt Chowrira had acquired 25,000 ordinary shares in the FTSE 250-listed biotechnology company.
-
Puretech Health narrows FY operating losses after cutting expenses
15 April 2021 07:52
(Sharecast News) - Biotechnology company Puretech Health said on Thursday that it had narrowed operating losses in 2020 on the back of a reduction in general and administrative expenses and a modest increase...
-
PureTech sells down Karuna stake as Vor closes IPO
10 February 2021 09:22
(Sharecast News) - Clinical-stage biotherapeutics commercialisation company PureTech Health announced on Wednesday that its founded entity Vor Biopharma has closed its initial public offering at a price of...
-
PureTech's Vor files for proposed Nasdaq IPO
18 January 2021 08:15
(Sharecast News) - PureTech Health announced on Monday that its founded entity Vor Biopharma has filed a public registration statement with the US Securities and Exchange Commission (SEC) for a proposed...
-
PureTech appoints George Farmer as new finance chief
5 January 2021 08:26
(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health announced on Tuesday that George Farmer has been appointed chief financial officer.
-
PureTech Health eyes Nasdaq listing for ADS
28 October 2020 08:01
(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health has filed a public registration statement to the US Securities and Exchange Commission as it looks to list its American depository...
Company announcements Announcements
-
PRTC's Vedanta Unveils New Manufacturing Facility
28 June 2022 12:35
PureTech Health
-
Transaction in Own Shares
28 June 2022 07:00
PureTech Health
-
Transaction in Own Shares
27 June 2022 07:00
PureTech Health
-
Transaction in Own Shares
24 June 2022 07:00
PureTech Health
-
Transaction in Own Shares
23 June 2022 07:00
PureTech Health
-
Transaction in Own Shares
22 June 2022 07:00
PureTech Health
-
GLS: New $15M Plenity Pre-Paid Order; $55M Total
21 June 2022 11:35
PureTech Health
-
Transaction in Own Shares
21 June 2022 07:00
PureTech Health
-
Transaction in Own Shares
20 June 2022 07:00
PureTech Health
-
Transaction in Own Shares
17 June 2022 07:00
PureTech Health
-
Transaction in Own Shares
16 June 2022 07:00
PureTech Health
-
Result of AGM
15 June 2022 18:00
PureTech Health
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2022. All rights reserved.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.